School of Rural Medicine, Pharmacy, University of New England, Armidale, NSW, Australia.
College of Medicine and Health Science, Clinical Pharmacy Department, University of Gondar, Gondar, Ethiopia.
Int J Clin Pract. 2021 Sep;75(9):e14356. doi: 10.1111/ijcp.14356. Epub 2021 May 24.
Inappropriate polypharmacy poses risks of adverse drug events, high healthcare costs and mortality. Deprescribing could minimise inappropriate polypharmacy and the consequences thereof. The aim of this study was to evaluate healthcare providers' (HCPs') attitudes toward and experiences with deprescribing practice in Ethiopia.
We conducted an institution-based cross-sectional survey among HCPs at the University of Gondar Comprehensive Specialized Hospital, Ethiopia. We used a validated questionnaire developed by Linsky et al. The tool included questions that explore medication characteristics, current patient clinical factors, predictions of future health states, patients' resources to manage their own health and education and experience. One-way ANOVA was used to test the association between sociodemographic variables and their perception of deprescribing decisions.
Of 85 HCPs approached, about 82 HCPs completed the survey, giving a response rate of 96.5%. Most of the participants (n = 73, 89%) have scored less than 1.5 points showing they are reluctant to proactively deprescribe. Physicians seem to be affected by the significant physical health conditions (mean = 1.68) and clinical endpoint like blood pressure (mean = 1.5) to make deprescribing decisions. According to the post hoc analysis of one-way ANOVA, clinical pharmacists seemed to have a better attitude toward deprescribing decisions compared with physicians (P = .025).
HCPs' decision to discontinue a medication could be multifactorial. Physicians could be influenced by physical health condition and clinical endpoints for deprescribing decision. Future studies should emphasise on barriers and facilitators to deprescribing practice specific to the context in Ethiopia.
不适当的多种药物治疗会带来药物不良事件、高医疗成本和死亡率的风险。减少用药可以最大限度地减少不适当的多种药物治疗及其后果。本研究旨在评估埃塞俄比亚医疗保健提供者(HCP)对减少用药实践的态度和经验。
我们在埃塞俄比亚贡德尔大学综合专科医院对 HCP 进行了一项基于机构的横断面调查。我们使用了由 Linsky 等人开发的经过验证的问卷。该工具包括探索药物特征、当前患者临床因素、对未来健康状况的预测、患者管理自身健康的资源以及教育和经验的问题。使用单因素方差分析检验社会人口统计学变量与他们对减少用药决策的看法之间的关系。
在接触的 85 名 HCP 中,约有 82 名 HCP 完成了调查,应答率为 96.5%。大多数参与者(n=73,89%)得分低于 1.5 分,表明他们不愿意主动减少用药。医生似乎受到重大身体健康状况(均值=1.68)和临床终点(如血压,均值=1.5)的影响来做出减少用药的决策。根据单因素方差分析的事后分析,临床药师似乎对减少用药决策的态度优于医生(P=0.025)。
HCP 停止用药的决定可能是多因素的。医生可能会受到身体健康状况和临床终点的影响来做出减少用药的决策。未来的研究应该强调针对埃塞俄比亚具体情况的减少用药实践的障碍和促进因素。